Cerity Partners’s TuHURA Biosciences HURA Stock Holding History

Cerity Partners’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63.2K	Buy	27,004 +12,144	+82%	+$28.3K	﹤0.01%	3276
2026 Q1	$26.6K	Buy	+14,860	New	+$18.2K	﹤0.01%	3164

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Cerity Partners's HURA Position: Q2 2026 in Review

Cerity Partners increased its TuHURA Biosciences (HURA) stake by 82% in Q2 2026, buying an estimated $28.3K and bringing the position to 27,004 shares worth $63.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3276.

Cerity Partners first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Cerity Partners held 27,004 shares of TuHURA Biosciences worth $63.2K as of Q2 2026.
Cerity Partners bought 12,144 TuHURA Biosciences shares in Q2 2026, an estimated $28.3K.
TuHURA Biosciences made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3276 holding.
Cerity Partners first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.